Stockreport

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update

FibroBiologics, Inc.  (FBLG) 
PDF Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 Improved balance sheet through m [Read more]